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Scope: Virgin olive oil is an essential component of the Mediterranean diet. Its antioxidant
and anti-inflammatory properties are mainly linked to phenolic contents. This study aims to
evaluate the beneficial effects of a polyphenol-rich virgin olive oil (HPCOO) or olive oil without
polyphenols (WPOO) in rats fed high-fat diet (HFD).
Methods and results: Male Sprague-Dawley rats were divided into four groups based on the
different types of diet: (I) standard diet (STD); (II) HFD; (III) HFD containing WPOO, and
(IV) HFD containing HPCOO. HPCOO and WPOO induced a significant improvement of
HFD-induced impaired glucose homeostasis (by hyperglycemia, altered oral glucose tolerance,
and HOMA-IR) and inflammatory status modulating pro- and anti-inflammatory cytokines
(TNF-, IL-1, and IL-10) and adipokines. Moreover, HPCOO and less extensively WPOO,
limited HFD-induced liver oxidative and nitrosative stress and increased hepatic fatty acid
oxidation. To study mitochondrial performance, oxidative capacity and energy efficiency were
also evaluated in isolated liver mitochondria. HPCOO, but not WPOO, reduced H2O2 release
and aconitase activity by decreasing degree of coupling, which plays a major role in the control
of mitochondrial reactive oxygen species emission.
Conclusion: HPCOO limits HFD-induced insulin resistance, inflammation, and hepatic ox-
idative stress, preventing nonalcoholic fatty liver disease progression.
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1 Introduction
Nonalcoholic fatty liver disease (NAFLD) is characterized
by insulin resistance (IR), hepatic steatosis and frequently
type 2 diabetes and is a major public health problem
in industrialized countries affecting up to 20–30% of
individuals [1]. NAFLD represents a multi-hit process
in which the accumulation of triglycerides increases the
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susceptibility to inflammatory damage, with subse-
quent onset of oxidative stress, mitochondrial dys-
function, endotoxemia, and endoplasmic reticulum
stress [2–4]. The excessive fatty acid oxidation and
mitochondrial dysfunction, with production of reactive
oxygen species (ROS), represent important features for
NAFLD progression toward nonalcoholic steatohepatitis
(NASH) [5]. Inflammatory cytokines, such as tumor necrosis
factor- (TNF-), transforming growth factor- (TGF-), and
IL-6, play a pivotal role in NAFLD onset. [6]. Also adipokines,
leptin and adiponectin, control inflammation and fat
metabolism are implicated in molecular mechanisms of
NAFLD [7]. The involvement of several pathways highlights
the strict connection between NAFLD and other metabolic
disorders, such as obesity, IR, and dyslipidemia [8,9]. To date,
althoughmany strategies have shown their efficacy in clinical
trials, the large-scalemanagement of NAFLD is very complex,
underlining the need to identify more effective approaches
[10].
Diet is a modifiable target in both prevention and treat-
ment of NAFLD and the Mediterranean diet has gained ever-
increasing importance for its capability to improve hepatic
steatosis and IR [11], limiting the progression of steatosis in
steatohepatitis. Virgin olive oil represents amajor component
of this dietary regimen and its beneficial effects on human
health are mainly related to the polyphenols content [12].
Phenolic compounds of olive oil with remarkable biological
activities are oleocanthal, oleuropein, and its derivatives hy-
droxytyrosol and tyrosol [13]. In vitro study demonstrated the
anti-inflammatory effect of oleuropein by inhibiting toll-like
receptor and mitogen-activated protein kinases signaling in
lipopolysaccharide stimulated RAW 264.7 and in a zebrafish
model [14]. The antiproliferative and anti-inflammatory ef-
fects of oleocanthal were previously examined in humanmul-
tiplemyeloma cell lineARH-77 and in chondrocytes, inwhich
a downregulation of ERK1/2 and protein kinase B (AKT) sig-
nal transduction pathways has been demonstrated [15, 16].
More recently, Lee et al. [17] showed that tyrosol protected
against -cell dysfunction and inhibited ER stress-induced
apoptosis in mouse insulinoma cells NT-1 through JNK sig-
naling. Moreover, our recent study demonstrated the bene-
ficial effects of hydroxytyrosol in NAFLD, reducing IR, in-
flammation, and oxidative stress in rats [18]. Nevertheless,
the benefits of polyphenol-rich virgin olive oil (HPCOO) in
NAFLD have not been explored yet.
To this purpose, the aim of this study was to evaluate
the effect of a virgin olive oil with high content of polyphe-
nols (HPCOO) in a rat model of NAFLD induced by high-
fat diet (HFD). We investigated the effect of HPCOO in
reducing IR, inflammation and oxidative stress, and patho-
logical features of steatosis. In particular, we evaluated HP-
COO supplementation on glucose homeostasis and liver mi-
tochondrial performance, oxidative capacity, and energy ef-
ficiency. To this aim, we also considered the effect of olive
oil containing lower tocopherol amount without polyphenols
(WPOO), in order to address the contribution of the high
polyphenol content contained in olive oil in limiting early
events in NAFLD.
2 Material and methods
2.1 Ethics statement
All procedures involving animals and their care were con-
ducted in conformity with international and national law and
policies (EU Directive 2010/63/EU for animal experiments,
ARRIVE guidelines and the Basel declaration including the
3R concept). The procedures reported here were approved by
the Institutional Committee on the Ethics of Animal Experi-
ments (CSV) of the University of Naples “Federico II” and by
the Ministero della Salute under protocol no. 2013/0040363.
As suggested by the animal welfare protocol, all efforts were
made to minimize animal suffering and to use only the num-
ber of animals necessary to produce reliable scientific data.
2.2 Diets and animal model design
Control pelleted diet (standard diet (STD), Global diet 2018)
was purchased fromHarlan Laboratories (Udine, Italy) and it
was composed of 17% fat, 23% proteins, 60% carbohydrates,
and 16.1 kJ/g diet of energy density. HFD was prepared as
previously described by Surwit et al. [19] from Laboratorio
Dottori Piccioni (Gessate, Milan, Italy) and contained 58,1%
of fat, 16% proteins, and 25,5% carbohydrates. To HFD was
added 1.3% w/w of a natural virgin olive oil rich in polyphe-
nols and tocopherols (HPCOO) or an olive oil containing
tocopherols without polyphenols (WPOO). The percentage
composition and energy density of enriched HFDs, as well
as fatty acid percentage and tocopherol content in HPCOO
and WPOO, are shown in Table 1. In addition, HPCOO con-
tained different polyphenolic components, absent in WPOO,
as shown in Table 2. The daily intake of polyphenols in rats
was about 0.290 mg/kg, which is the amount included in the
range of polyphenol daily intake in human. It is expressed as
"human equivalent dose" [20].
Male Sprague-Dawley rats (113.5 ± 1.1 g; Harlan, Corez-
zano, Italy) were housed in cages in a room kept at 22 ± 1C
on a 12/12 h light/dark cycle. Animals were divided into four
groups (n = 6 for each group) based on the different types
of diet, as following: (I) STD; (II) HFD; (III) HFD enriched
with WPOO (HFD + WPOO), and (IV) HFD enriched with
HPCOO (HFD + HPCOO).
In our experimental conditions, early events of NAFLD
and IR were induced by fat overnutrition, through the ad-
ministration of this fat diet in young rats for 6 wks, excluding
age and gender influences [21, 22]. After 5 wks of treatment
oral glucose tolerance test (OGTT) was performed. At the
end of experiment (6 wks), overnight fasted animals were
anaesthetized by enflurane followed by cervical dislocation
and serum and tissues were collected.
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Table 1. Composition of HFDs enriched with olive oils containing
(HFD + HPCOO) or not (HFD + WPOO) polyphenols
Diet composition HFD + HPCOO HFD + WPOO
Lipid 59.4 59.4
Carbohydrate (%) 24,2 24,2
Protein (%) 16 16
Energy density kJ/g diet 22.8 22.8
Fatty acid composition
(%)
HPCOO WPOO
C 16:0 Palmitic 13.7 v
C 16:1 (9) Palmitoleic 0.1 0.1
C 16:1 (7) Palmitoleic 1.1 0.8
C 17:0 Eptadecenoic 0.0 0.1
C 17:1 Eptadecenoic 0.1 0.1
C 18:0 Tearic 1.8 2.7
C 18:1 (9) Oleic 65.4 70.7
C 18:1 (7) Vaccenic 4.7 4.0
C 18:2 (6) Linoleic 10.5 8.9
C 20:0 Arachic 0.3 0.4
C 18:3 (3) Linolenic 0.8 0.5
C 20:1 Eicosanoic 0.3 0.3
C 22:0 Behenic 0.1 0.1
Squalen 0.9 0.3
C 24:0 Lignoceric 0.1 0.1
ratio linolenic
(3)/linoleic (6)
0.08 0.06
Tocopherols (mg/100 g
of oil)
HPCOO WPOO
-tocopherol 43.3 16.5
+ tocopherol 3.2 2.1
 tocopherol nq nq
Total phenolic content
(mg/kg of oil)
HPCOO WPOO
404.1a) –
Fatty acid percentage and tocopherol content in HPCOO and in
olive oil without polyphenol (WPOO) are also shown.
a) For the phenolic content and composition see Table 2.
2.3 Body weight gain and fat mass
Body weight was monitored two times per week and body
weight gain was calculated as difference between the last
measure and the body weight recorded at the beginning of
the experiment. Before euthanasia, bioelectrical impedance
analysis was performed to body composition assessment
using a BIA 101analyzer, modified for the rat (Akern,
Florence, Italy). Fat-free mass was calculated using the bio-
electrical impedance analysis (50 kHz) prediction equation of
Ilagan et al. [23], and fat mass content was determined as the
difference between body weight and fat-free mass. Total liver
lipids were extracted as previously described [24].
2.4 OGTT and serum parameters
At the fifth week of the experimental period, fasted rats re-
ceived glucose (2 g/kg; per os) and glycemia was measured
at time 0, 30, 60, 90, and 120 min. Glucose levels were mea-
sured by the glucometer One Touch UltraSmart (Lifescan,
Milpitas, CA). Serum ALT and triglycerides were analyzed by
standard automated procedures, according tomanufacturer’s
protocols (AST Flex R© reagent cartridge, ALT Flex R© reagent
cartridge, Dade Behring Inc., Newark, DE). Commercially
available ELISA kits were used to determine insulin (Mer-
codia, Uppsala, Sweden), adiponectin and leptin (B-Bridge
International, Mountain View, CA), TNF-, IL-1, and IL-10,
(Thermo Scientific, Rockford, IL), following the manufac-
turer’s instructions. Glucose levels were determined using
glucose monitor (BRIO, Ascensia, NY) calibrated for rats.
As index of IR, HOMA-IR (homeostasis model assessment)
was obtained, using the formula (HOMA = fasting glucose
(mmol/L) × fasting insulin (U/mL)/22.5).
2.5 Western blot analysis
Liver (100 mg wet tissue) was homogenized on ice in lysis
buffer (20mMTris–HCl, pH 7.5, 10mMNaF, 150mMNaCl,
1% Nonidet P-40, 1 mM phenylmethylsulphonyl fluoride, 1
mM Na3VO4, leupeptin, and trypsin inhibitor 10 g/mL).
After 40 min, total protein lysates were obtained by centrifu-
gation at 14 000 × g for 15 min at 4C. Protein concentrations
were estimated by the Bio-Rad protein assay using BSA as
standard and equal amount of protein (50 g) were subjected
to SDS-PAGE and electrotransferred onto a nitrocellulose
membrane (Amersham Biosciences, Little Chalfont, Buck-
inghamshire,UK) using aBio-RadTransblot (Bio-Rad,Milan,
Table 2. Phenolic and polyphenolic composition of high-polyphenol content olive oil (HPCOO)
Phenolic and polyphenolic components of HPCOO (mg/kg of oil)
Phenolic acids Secoiridoids Lignans Secoiridoids
OHTy Ty OHTyEDA TyEDA Pr OHTyEA TyEA Total phenols
Hydroxytyrosol Tirosol Dialdehydic
form of
oleuropein
aglycone
Oleochantal Pinoresinol Aldehydic
form of
oleuropein
aglycone
Aldehydic
form of
ligstroside
aglycone
404.1
4.4 6.0 179.2 92.6 40.2 62.3 5.9
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Italy). Membranes were blocked at room temperature inmilk
buffer (1×PBS, 10%w/v nonfat drymilk, 0.1% v/v Tween-20)
and then incubated at 4C overnight with anti-nitrotyrosine
(Nox-Tyr) and anti-GLUT2 (Merck Millipore, Billerica, MA,
USA), anti-phospsho-Akt, for the residue Thr308, and anti-
Akt (Cell Signaling, Danvers, MA, USA). Subsequently, the
membranes were incubated for 90 min at room temperature
with peroxidase-conjugated appropriate antibodies (Jackson
ImmunoResearch Laboratories, Baltimore Pike, West Grove,
PA). Western blot for glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH, Sigma-Aldrich, Milan, Italy) was performed
to ensure equal sample loading.
2.6 RNA extraction and Real-time semi-quantitative
PCR
Total RNA was extracted from liver tissues using TRI-
zol Reagent (Bio-Rad Laboratories), according to the man-
ufacturer’s instructions. cDna was synthesized using a re-
verse transcription kit (NucleoSpin R©, MACHEREY-NAGEL
GmbH & Co, Du¨ren, Germany) from 2 g total RNA. PCRs
were performed with a Bio-Rad CFX96 Connect Real-time
PCRSystem instrument and software (Bio-Rad Laboratories).
The PCR conditions were 15 min at 95C followed by 40 cy-
cles of two-step PCR denaturation at 94C for 15 s, anneal-
ing at 55C for 30 s and extension at 72C for 30 s. Each
sample contained 1–100 ng cDNA in 2× QuantiTect SYBR-
Green PCR Master Mix and primers, Tnf, Cox2 and Peroxi-
some proliferator-activated receptor gamma (Ppara) (Qiagen,
Hilden, Germany) in a final volume of 50 l. The relative
amount of each studied mRNA was normalized to GAPDH
as housekeeping gene, and data were analyzed according to
the 2-		CT method.
2.7 Measurements of mitochondrial oxidative
capacities and degree of coupling
Mitochondria isolation and oxygen consumption (polaro-
graphically measured using a Clark-type electrode) were
carried out as previously reported [25]. Briefly, the livers
were finely minced and washed in a medium containing
220 Mm mannitol, 70 mM sucrose, 20 mM N′-(2-
hydroxyethyl) piperazine-N-2-ethanesulfonic acid (HEPES)
(pH 7.4), 1 mM-EDTA, and 0.1 % w/v fatty acid free BSA.
Tissue fragments were homogenised with the abovemedium
(1:4, w/v) in a Potter Elvehjem homogeniser (Heidolph, Kel-
heim, Germany) set at 500 rpm (4 strokes/min). The ho-
mogenate was centrifuged at 1000 gav for 10 min and the
resulting supernatant fraction was again centrifuged at 3000
× g for 10 min. The mitochondrial pellet was washed twice
and finally resuspended in a medium containing 80 mM
KCl, 50 mM HEPES (pH 7.0), 5 mM KH2PO4, and 0.1% w/v
fatty acid free BSA. The protein content of the mitochon-
drial suspension was determined by the method of Hartree
[26] using BSA as the protein standard. Isolated mitochon-
dria were then used for the determination of respiratory
parameters.
Oxygen consumption was measured in the presence of
substrates and ADP (state 3), in the presence of substrates
alone (state 4) and their ratio (respiratory control ratio, RCR)
were calculated. The substrates used for liver respirationwere
10 mM succinate + 3.75 M rotenone or 40 M palmitoyl-
carnitine+ 2.5 mMmalate for the determination of fatty acid
oxidation rate.
The degree of coupling was determined in the liver by
applying equation by Cairns et al. [27]: degree of coupling =√
1 − (Jo)sh/(Jo)unc where (Jo)sh represents the oxygen con-
sumption rate in the presence of oligomycin that in-
hibits ATP synthase, and (Jo)unc is the uncoupled rate
of oxygen consumption induced by carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), which dissipates
the transmitochondrial proton gradient. (Jo)sh and (Jo)unc
were measured as above using succinate (10 mmol/L)
rotenone (3.75 mol/L) in the presence of oligomycin
(2 g/mL) or FCCP (1 mol/L), respectively.
The rate of mitochondrial H2O2 release was assayed by
following the linear increase in fluorescence (ex 312 nm
and em 420 nm) due to the oxidation of homovanillic acid
in the presence of horseradish peroxidase [28]. Aconitase
activity was measured spectrophotometrically (at 412 nm).
Determination of aconitase specific activity was carried out
in a medium containing 30 mM sodium citrate, 0.6 mM
MnCl2, 0.2 mM NADP, 50 mM TRIS-HCl pH 7.4, and two
units of isocitrate dehydrogenase. The formation of NADPH
was followed spectrophotometrically (340 nm) at 25C. The
level of aconitase activity measured equals active aconitase
(basal level). Aconitase inhibited by ROS in vivo was reac-
tivated so that total activity could be measured by incubat-
ing mitochondrial extracts in a medium containing 50 mM
dithiothreitol, 0.2mMNa2S, and 0.2mM ferrous ammonium
sulphate [29].
2.8 ROS assay
The levels of ROS were determined as previously reported
[30]. An appropriate volume of freshly prepared tissue ho-
mogenate was diluted in 100 mM potassium phosphate
buffer (pH 7.4) and incubated with a final concentration
of 5 M dichlorofluorescein diacetate (Sigma–Aldrich) in
dimethyl sulfoxide for 15 min at 37C. The dye-loaded sam-
ples were centrifuged at 12 500 × g for 10 min at 4C. The
pellet was mixed at ice-cold temperatures in 5 mL of 100 mM
potassium phosphate buffer (pH 7.4) and again incubated for
60 min at 37C. The fluorescence measurements were per-
formedwith aHTS-7000Plus plate reader spectrofluorometer
(Perkin Elmer, Wellesley, MA, USA) at 488 nm for excitation
and 525 nm for emission wavelengths. ROS were quantified
from the dichlorofluorescein standard curve in dimethyl sul-
foxide (0–1 mM).
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2.9 MDA measurement
Malondialdehyde (MDA) levels in the liver were determined
as an indicator of lipid peroxidation [31]. Tissues were ho-
mogenized in 1.15% KCl solution. An aliquot (200 L) of
the homogenate was added to a reaction mixture containing
200 L of 8.1% SDS, 1.5 mL of 20% acetic acid (pH 3.5),
1.5mL of 0.8% thiobarbituric acid, and 600L of distilled wa-
ter. Samples were then boiled for 1 h at 95C and centrifuged
at 3000× g for 10min. The supernatant absorbance wasmea-
sured by spectrophotometry at 550 nm and the concentration
of MDA was expressed as micromolar MDA per milligram
protein of cell homogenate. A standard curve was prepared
using MDA bisdimethylacetal as the source of MDA.
2.10 Statistical analysis
Data are presented as mean ± SEM. Statistical analysis was
performed by analysis of variance test for multiple compar-
isons followed by Bonferroni’s test to evaluate significance
in differences among all groups, using Graph-Pad Prism
(Graph-Pad software, San Diego, CA, USA). Statistical sig-
nificance was set at p < 0.05.
3. Results
3.1 Polyphenol-rich olive oil improves glucose and
lipid homeostasis
SerumALT and triglycerides were increased byHFD feeding.
The addition of HPCOO to diet reduced significantly these
biochemical parameters, typical of NAFLD (Table 3). Weight
gain and fat mass of animals did not change among groups,
while the total lipid content resulted significantly higher
in HFD rats, but it was significantly reduced by HPCOO
(Table 3). No variation in food intake was shown between
the HFD and WPOO and HPCOO fed animals (108.7 ± 6.9
versus 105.9 ± 6.0 and 110.3 ± 6.6 g/week, respectively).
After 5 wks of HFD feeding the OGTT was performed.
HPCOO and WPOO showed a trend of reduction on
glycemia in HFD animals at all time examined, raising the
significance analyzing the area under the curve (Fig. 1A);
HPCOO effect was more evident than that of WPOO. After 6
wks, fasting serum glucose levels (Fig. 1B) were significantly
higher in HFD rats than STD, WPOO and HPCOO and
insulinemia showed a trend of reduction only for HPCOO
(Fig. 1C). Accordingly, IR assessed by HOMA-IR index re-
sulted significantly improved by HPCOO, more than WPOO
(Fig. 1D).
To confirm the effect of HPCOO and WPOO on IR, we
evaluated the phosphorylation of AKT and GLUT2 expres-
sion in liver (Fig. 2A and B). HPCOO, and less extensively
WPOO, increased the levels of these parameters improv-
ing glucose homeostasis. We also examined AMP-activated
protein kinase (AMPK) phosporilation and the transcription
of its downstream gene, peroxisome proliferator-activated
receptor- (PPAR-) (Fig. 2C and D), which confirmed the ef-
ficacy of HPCOO, and partially of WPOO, on fat metabolism
in liver.
3.2 Effect of polyphenols on serum levels of
inflammatory cytokines and adipokines
The unbalance between pro-inflammatory (TNF- and IL-
1) and anti-inflammatory mediators (IL-10) plays a key role
in the liver damage and the pathogenesis of hepatic IR.
HPCOO significantly improved the serum levels of these
parameters altered by HFD (Fig. 3A–C). Consistently, HP-
COO also positively modulated the serum levels of leptin
and adiponectin, two of the most important pro- and anti-
inflammatory adipokines, respectively (Fig. 3D and E). No
significant difference on these parameters was revealed after
addition of WPOO in diet (Fig. 3A–E).
3.3 WPOO and HPCOO reduce liver inflammation
and oxidative stress
Liver inflammation induced by HFD was also evaluated
(Fig. 4). HPCOO andWPOOwere able to significantly reduce
TNF- and cyclooxygenase-2 (COX-2) mRNA levels (Fig. 4A
and B).Moreover, HFD caused a significant increase of oxida-
tive damage from ROS and reactive nitrogen species (RNS),
which mainly contribute to the hepatic damage. WPOO and
to greater extent HPCOO reduced nitrosilation of proteins
and decreased ROS production (Fig. 4C and D). In addition,
we evaluated the levels of MDA, as amarker of lipid peroxida-
Table 3. Body, serum, and liver parameters
STD (n = 6) HFD (n = 6) HFD + WPOO (n = 6) HFD + HPCOO (n = 6)
Body weight gain (g) 246.8 ± 27.22a 253.9 ± 13.13a 266.1 ± 8.60a 254.6 ± 8.11a
Fat mass (g) 76.7 ± 8.04a 83.1 ± 4.34a 77.2 ± 4.05a 64.0 ± 4.78a
Serum ALT (U/L) 32.1 ± 3.40a 40.4 ± 3.69b 39.4 ± 3.50b 33.8 ±2.24a
Serum tryglicerides (mg/dL) 50.8 ± 1.70a 71.4 ± 2.09b 69.6 ± 1.63b 62.2 ±0.97c
Total liver lipids (mg/g tissue) 35.6 ± 0.78a 57.9 ± 0.61b 57.6 ± 3.42b 49.9 ± 0.15c
Data reported in table are mean ± SEM of six rats per group. All results were considered statistically significant at p < 0.05. Differences
among groups are indicated by letters (a, b, c, d).
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Figure 1. Effect of WPOO or HPCOO
on glucose homeostasis and insulin
resistance. OGTT in STD- and HFD-
fed rats (n=6, each group) was per-
formed and AUC evaluated (A). Fast-
ing glucose (B), insulin levels (C),
and HOMA-IR (D) were also reported
(n=6, each group). All results were
considered statistically significant at
p < 0.05. Differences among groups
are indicated by letters (a, b, c, d).
tion, and an increase of these levels inHFD-fed group than in
STD group was revealed. WPOO and HPCOO significantly
also decreased MDA levels (Fig. 4E). As demonstrated by a
previous study [32], the presence of tocopherols in WPOO
justifies its anti-oxidant effect, even if this capability is lower
than that of HPCOO.
3.4 HPCOO increases fatty acid oxidation in hepatic
mitochondria
Because mitochondria are the main site of the substrate
oxidative process, we analyzed respiratory rates in isolated
liver mitochondria. Oxidative mitochondrial respiratory ac-
tivity was determined by using FADH2-linked substrates
(succinate plus rotenone) and palmitoyl-carnitine a substrate
to assess the capacity of lipid substrate oxidation.
Mitochondria from HFD animals exhibited a significant
lower state 3 respiration rate than STD and HFD + HPCOO
in presence of succinate, as substrate (Fig. 5A). State 3, in
presence of palmitoylcarnitine, was significantly higher in
mitochondria of HFD, HFD + WPOO, and HFD + HPCOO
than those measured in STD rats (Fig. 5B). Moreover HFD
+ HPCOO value significantly differed from the other ones.
A not significant increasing trend in H2O2 levels in mito-
chondria was shown in HFD and HFD + WPOO fed groups
compared to STD, HPCOO administered in the diet signif-
icantly reduced H2O2 levels compared to HFD group (Fig.
5C). Interestingly, even if the increase in palmitoylcarnitine
amount indicates a more significant fatty acid oxidation in
HFD + HPCOO, it is not related to an increase of H2O2
yield as result of oxidative stress. In fact, H2O2 was signifi-
cantly reduced by the addition of HPCOO to diet. Similarly,
a lower aconitase activity was found in HFD and HFD +
WPOO compared to STD group but was significantly higher
in the HFD + HPCOO than in the HFD (Fig. 5D). To test
mitochondrial efficiency, we measured oxygen consumption
in presence of oligomycin and FCCP. Oligomycin state 4 res-
piration showed a trend of reduction in HFD and WPOO
animals than STD whereas was significantly increased in
HFD + HPCOO (Fig. 5E), while no variation was found in
maximal FCCP-stimulated respiration (Fig. 5F). As a conse-
quence, hepatic mitochondrial energetic efficiency, assessed
as degree of coupling, was significantly higher in HFD and
WPOOanimals than STDand significantly decreased inHFD
+ HPCOO (Fig. 5G).
4 Discussion
Evidences support the beneficial effects ofMediterranean diet
on human health, specifically on NAFLD [33–36]. Among the
components of this dietary regimen (cereals, vegetables, and
legumes), olive oil and its phenolic content, which present
important biological activities, are currently under investi-
gation [37–39]. In our study, we comparatively evaluated the
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Figure 2. Effect of WPOO or HPCOO on
metabolic impairment in liver from HFD
fed rats. Levels of pAKT (A), GLUT2 (B) and
pAMPK expression (C) in the liver lysates
were measured by western blot analysis
(n = 6 each group). A representative blot
of pAKT and AKT, p-AMPK, and AMPK and
the ratios from densitometric analysis of
bands from all samples are also shown.
mRNA transcriptional levels of Pparawere
also shown (D). Data are mean ± SEM of
six rats per group. All results were consid-
ered statistically significant at p< 0.05. Dif-
ferences among groups are indicated by
letters (a, b, c).
Figure 3. Effect of HPCOO on
cytokine and adipokine serum
levels. TNF- (A) IL-1 (B), and
IL-10 (C) are reported. Panels D
and E show serum levels of lep-
tin and adiponectin in all groups
of rats. Data are mean ± SEM
of six rats per group. All re-
sults were considered statisti-
cally significant at p < 0.05. Dif-
ferences among groups are in-
dicated by letters (a, b, c).
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Figure 4. Effect of WPOO or HP-
COO on Tnf and Cox-2 mRNA
levels and nitrosative and oxida-
tive stress. Tnf (A) and Cox-2 (B)
mRNA was shown. Protein ni-
trosylation (C) in liver from STD
and HFD rats fed or not with
WPOOor HPCOO is shown. ROS
production (D) and MDA con-
tent (E) are also reported. Val-
ues are reported as means ±
SEM of at least six animals. All
results were considered statisti-
cally significant at p < 0.05. Dif-
ferences among groups are in-
dicated by letters (a, b).
beneficial effects of HPCOO and WPOO in limiting
the progression of early events of NAFLD. As we previ-
ously described [18], 6-wks HFD feeding is able to mimic
pathogenetic mechanisms of hepatic fatty acid accumulation
and glucose metabolism alteration. HPCOO and WPOO
showed beneficial effects in restoring insulin sensitivity,
reducing glycaemia, and HOMA-IR index. This effect
on glucose homeostasis was more evident in HPCOO
group than WPOO, underlining polyphenol contribution in
limiting IR. Moreover, only HPCOO reduced also serum
triglycerides and ALT, and all total liver lipids, parameters
that characterize the HFD-induced NAFLD pattern.
The PKC/IRS/Akt signaling pathway plays a pivotal role
in glucose response, whose impairment induces to accumu-
lation of lipotoxic intermediates and development of IR [40].
In the liver, the activation of Akt leads to glucose uptake and
gluconeogenesis inhibition, limiting NAFLD progression. In
our experiment, we showed that WPOO and even more HP-
COO are able to activate Akt and increase GLUT2 expres-
sion in liver, promoting glucose uptake and restoring insulin
sensitivity, compromised in HFD rats. Consistently, it has
been demonstrated that postnatal administration of resvera-
trol, a polyphenolic compound, modulated themetabolic pro-
file of HFD-fed offspring, acting on PKC/IRS/Akt signaling
[41].
The characteristic visceral adiposity of NAFLD is strictly
correlated with a dysregulation of a variety of adipokines
[42]. The unbalanced secretion of pro-steatosic and pro-
inflammatory (leptin and TNF-) and anti-steatosic and anti-
inflammatory adipokines (adiponectin) is an important fea-
ture of the progression of NAFLD toward NASH [7]. In
HFD-fed mice, a polyphenol-rich grape extract supplemen-
tation was able to reduce plasma leptin levels and to increase
adiponectin ones [43]. Moreover, in a randomized controlled
trial, Chen et al. [44] demonstrated that resveratrol reduced
serum TNF- and improved adiponectin levels in patients
with NAFLD. In agreement with these data, we demonstrated
that HPCOO, conversely to WPOO, was able to improve
adipokine balance altered by HFD feeding.
The adipose tissue following overnutrition secretes in-
flammatory cytokines, such as TNF-, IL-1, and IL-6. These
cytokines downregulate insulin sensitivity of hormone sen-
sible organs, such as liver, whose metabolic activity is
strongly influenced by insulin signaling. In fact, defects in the
C© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Figure 5. Effect of HPCOO on hep-
atic mitochondrial functions and
energy efficiency. Mitochondrial
respiration in the presence of suc-
cinate (A) or palmitoyl-carnitine
(B) as substrates was determined
in liver. H2O2 yield (C), aconitase
activity (D), oxygen consumption
in the presence of oligomycin (E),
or uncoupled by FCCP (F), and
degree of coupling values calcu-
lated from oxygen consumption
in the presence of oligomycin and
uncoupled by FCCP (G) are also
shown. Values are reported as
means ± SEM of at least six an-
imals. All results were considered
statistically significant at p < 0.05.
Differences among groups are in-
dicated by letters (a, b, c).
insulin signaling pathways contribute to accumulation of free
fatty acids in organs and lead to the phosphorylation of sev-
eral substrates [8]. In an in vivo study, resveratrol was able
to decrease lipogenesis and inflammation induced by HFD,
reducing TNF-, IL-6, and NF-
B mRNA expression in the
liver [45].Moreover, the supplementation of this polyphenolic
compound in healthy dietary regimen reduced serum inflam-
matory markers in patients with NAFLD [46]. In our study,
the high content of polyphenols in virgin olive oil was able
to significantly reduce the inflammation induced by HFD.
Indeed, this beneficial effect was characterized by a decrease
of TNF-, IL-1, and an increase of IL-10 serum levels, while
WPOO did not reach significant anti-inflammatory effect. As
it happens for adipokines, the effects of HPCOO were higher
than that induced byWPOO, underlining again the efficacy of
polyphenols olive oil in limiting NAFLD. In addition, the two
formulation of olive oil were able to reduce TNF- and COX-2
transcription, confirming their anti-inflammatory activity in
liver tissue.
The role of adiponectin, inhibited by TNF-, IL-6 and re-
sistin, in limiting IR is based on a stimulation of mitochon-
drial -oxidation, by activating AMPK, and an inhibition of
lipogenesis by downregulating SREBP-1c [47]. Experimental
study demonstrated the reduction of phosphorylated AMPK
protein expression induced by HFD [48], suggesting a strong
involvement of AMPK signaling impairment in pathological
onset of NAFLD. In LDL receptor deficientmice fed aHFD, it
was demonstrated that polyphenols of rooibos extracts were
able to prevent steatosis via AMPK activation [49]. Consis-
tently with these findings, we showed that HPCOO positively
acts on fatty acid metabolism and IR, inducing the activation
of AMPK and the transcription of PPAR, its downstream
gene. Interestingly, WPOO also plays a similar profile of ac-
tivity, probably due to the presence of tocopherols. In fact,
other studies demonstrated the beneficial effects of vitamin E
on lipid metabolism and insulin sensitivity in murine mod-
els of steatosis and NASH [50, 51]. Here, WPOO and more
significantly HPCOO are able to improve IR in HFD-fed ani-
mals via AMPK activation and restoration of Akt signaling in
liver and increasing GLUT2 expression.
Another feature of pathogenetic mechanism of NAFLD
is the increase of oxidative stress, caused by hepatic fatty
acid accumulation and IR [5]. Oxidative damage is character-
ized by a redox unbalance with excessive release of ROS and
RNS. The production of ROS triggers TNF- secretion, which
increases the damage of mitochondrial membrane, with the
consequent release of cytochrome c, and following hepatocyte
death [52]. The production of ROS occurred mainly in mito-
chondria leading to its dysfunction, key feature of NAFLD
pathogenesis [53].
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Here, oxidative capacity and energy efficiency were eval-
uated in hepatic mitochondria obtained from different rat
groups, since both parameters could affect mitochondrial
performance. We demonstrated that HPCOO improves fatty
acid oxidation rate and reduces ROS (i.e. reduction of H2O2
release and increase of basal aconitase/total aconitase ratio)
by decreasing degree of coupling that plays a major role in
the control of mitochondrial ROS emission.
The presented results confirm the association between
HFD-induced ectopic fat storage in the liver and mitochon-
drial alterations [54]. Accordingly, HFDhepaticmitochondria
exhibited reduced respiratory capacity, as indicated by the
decrease in succinate state 3 oxygen consumption, and
increased oxidative stress, when the ability to utilize fat as
a metabolic fuel was elevated, such as in HFD fed animals.
Moreover, a further mechanism contributing to fat accumu-
lation could be the enhanced mitochondrial efficiency, as
shown by the increase in the degree of coupling in HFD
rats. Increased mitochondrial energetic efficiency implies
that less substrates need to be burned to obtain the same
amount of ATP, while higher plasma triglycerides found in
HFD rats fed dictate higher lipid substrate flux to the liver.
As a consequence, it is possible that a condition of imbalance
takes place in the hepatic cell, with substrate influx exceeding
substrate burning and favoring ectopic lipid deposition.
The increase of fatty acids oxidation rate might play a cru-
cial role in enhancing ROS production [55], as suggested by
the increased H2O2 production observed in HFD rats. More-
over, higher degree of coupling should imply increased ROS
production, in fact, one of the postulated roles of uncoupling
is known to be the maintenance of mitochondrial membrane
potential below the critical threshold for ROS production [56].
The improvement of respiratory capacity, fatty acid oxi-
dation, oxidative stress, and the decreased mitochondrial ef-
ficiency, showed by HPCOO rats may be interpreted as the
result of converging protective mechanisms against NAFLD,
preventing its progression.
In our previous study, we demonstrated the anti-oxidant
effect of hydroxytyrosol, a main metabolite of oleuropein, in
liver steatosis induced in rat by HFD feeding [18]. Accord-
ingly, in this study the polyphenol-rich olive oil was able to
limit the oxidative and nitrosative stress, reducing the produc-
tion of ROS and RNS and consequent lipid peroxidation. This
effect was shown in bothHPCOO andWPOO, indicating that
the anti-oxidant activity can be linked not only to polyphenol
content, but also to other substances, such as tocopherols,
rather than omega-3 and omega-6, whose concentrations are
similar in both oils examined. In fact, the beneficial effect of
tocopherols has been already reported in experimental and
clinical studies [32, 57].
In conclusion, we showed the protective effects ofHPCOO
against NAFLD induced by fat overnutrition. In particular,
HPCOO, more than WPOO, is able to significantly reduce
liver inflammation and mitochondrial oxidative stress and to
restore insulin sensitivity. These data support the importance
of polyphenolic content in olive oil, one of major components
of Mediterranean diet, suggesting its pivotal role to limit liver
injury and associated disorders in the onset of NAFLD and
its progression in NASH.
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